|Home use of an artificial beta cell in type 1 diabetes|
H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ...
New England Journal of Medicine 373 (22), 2129-2140, 2015
|Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial|
M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell, ME Wilinska, ...
The Lancet 392 (10155), 1321-1329, 2018
|Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial|
R Hovorka, D Elleri, H Thabit, JM Allen, L Leelarathna, R El-Khairi, ...
Diabetes care 37 (5), 1204-1211, 2014
|Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily …|
SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ...
Diabetes care 37 (8), 2114-2122, 2014
|Flash forward: a review of flash glucose monitoring|
L Leelarathna, EG Wilmot
Diabetic Medicine 35 (4), 472-482, 2018
|Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial|
D Elleri, JM Allen, K Kumareswaran, L Leelarathna, M Nodale, K Caldwell, ...
Diabetes care 36 (4), 838-844, 2013
|Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study|
H Thabit, A Lubina-Solomon, M Stadler, L Leelarathna, E Walkinshaw, ...
The lancet Diabetes & endocrinology 2 (9), 701-709, 2014
|Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European …|
O Moser, MC Riddell, ML Eckstein, P Adolfsson, R Rabasa-Lhoret, ...
Diabetologia 63 (12), 2501-2520, 2020
|Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents|
KD Barnard, T Wysocki, JM Allen, D Elleri, H Thabit, L Leelarathna, ...
BMJ Open Diabetes Research and Care 2 (1), e000025, 2014
|Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study|
L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ...
Diabetes Care 37 (7), 1931-1937, 2014
|Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study|
J Lawton, M Blackburn, J Allen, F Campbell, D Elleri, L Leelarathna, ...
BMC endocrine disorders 18 (1), 1-10, 2018
|Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial|
L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ...
Critical Care 17, 1-12, 2013
|Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality|
K Winkley, H Sallis, D Kariyawasam, LH Leelarathna, T Chalder, ...
Diabetologia 55, 303-310, 2012
|Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy|
KD Barnard, T Wysocki, V Ully, JK Mader, TR Pieber, H Thabit, ...
Journal of diabetes science and technology 11 (6), 1080-1088, 2017
|Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient …|
YM Luijf, JH DeVries, K Zwinderman, L Leelarathna, M Nodale, ...
Diabetes care 36 (12), 3882-3887, 2013
|Hybrid closed‐loop therapy: where are we in 2021?|
L Leelarathna, P Choudhary, EG Wilmot, A Lumb, T Street, P Kar, SM Ng
Diabetes, Obesity and Metabolism 23 (3), 655-660, 2021
|Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial|
E Bosi, P Choudhary, HW de Valk, S Lablanche, J Castañeda, S de Portu, ...
The lancet Diabetes & endocrinology 7 (6), 462-472, 2019
|Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice|
RA Ajjan, MH Cummings, P Jennings, L Leelarathna, G Rayman, ...
Diabetes and Vascular Disease Research 15 (3), 175-184, 2018
|Consensus recommendations for the use of automated insulin delivery technologies in clinical practice|
M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ...
Endocrine reviews 44 (2), 254-280, 2023
|Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK|
MJ Carr, AK Wright, L Leelarathna, H Thabit, N Milne, N Kanumilli, ...
The lancet Diabetes & endocrinology 9 (7), 413-415, 2021